异基因造血干细胞移植后并发自身免疫性溶血性贫血患者产生类抗体血清学检测方法及输血策略

doi:10.3877/cma.j.issn.1674-0785.2022.05.015

目的

探讨异基因造血干细胞移植（AHSCT）后免疫介导的自身免疫性溶血性贫血（AIHA）患者交叉配血不合的原因，血浆中不规则抗体筛选试验阳性时，不规则抗体鉴定的血清学检测方法的选择，处理措施及输血策略。

方法

一例AHSCT后的3岁男性患儿因重度贫血为改善贫血症状需输注红细胞入住四川省人民医院。通过盐水试管法确定了患儿ABO、Rh血型后进行交叉配血试验发现患儿与多个同型供者血液不相合，考虑到患儿贫血严重，于是采用直接抗球蛋白试验来判断红细胞是否被致敏；通过盐水介质试管法、微柱抗球蛋白法和聚凝胺法进行ABO血型系统以外的不规则抗体筛选试验以确定血浆中有无不规则抗体；根据不规则抗体筛选试验结果选择聚凝胺法来确定抗体的特异性；通过盐水介质试管法、经典抗球蛋白法和聚凝胺法进行交叉配血实验，结合抗体鉴定的结果，综合分析选择合适的供者红细胞输注。

结果

本例患儿ABO血型为AB型，Rh分型为CCDee，ABO血型已转变为供者血型。直接抗球蛋白试验强阳性，红细胞被抗体致敏。血浆中检出了不规则抗体，红细胞上放散下来的致敏抗体与血清中检出的不规则抗体均为类抗-Ce自身抗体。选择了避开类抗-Ce抗体的Ce抗原阴性的AB型红细胞输注后血色素升高，3 d后复查血常规Hb为79 g/L，输血有效。

结论

任何类型的AHSCT后都有可能发展成AIHA，也就是血浆中可能存在某种自身抗体（类抗体）而破坏自身红细胞，若能够明确患者血清中存在的类抗体，即可避开这种抗体而筛选红细胞无相应抗原的供者，也就避免发生溶血性输血反应以安全输血。

关键词: 异基因造血干细胞移植, 自身免疫性溶血性贫血, 自身抗体, 同种抗体, 类抗体, 安全输血

Objective

To investigate the causes of cross-matching incompatibility in patients with autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (AHSCT), and the selection of serological detection methods for irregular antibody identification, treatment measures, and blood transfusion strategies when the irregular antibody screening test in plasma is positive.

Methods

A child aged 3 years with severe anemia following AHSCT was hospitalized at Sichuan Provincial People's Hospital for red blood cell (RBC) transfusion in order to alleviate the symptoms of anemia. The ABO and Rh blood groups of the child were determined through the brine test method, and then the cross-matching test was carried out. It was found that the blood of the child was inconsistent with that of multiple homogeneous donors. Considering the serious anemia of the child, the direct antiglobulin test was performed to judge whether the RBC was sensitized; irregular antibody screening tests outside the ABO blood group system were carried out using the brine test tube method, and microcolumn antiglobulin method and polybrene method were used to determine whether there were irregular antibodies in plasma. According to the results of the irregular antibody screening test, the polybrene method was selected to determine the specificity of antibody; the cross-matching experiment was carried out by the brine test tube method, classical antiglobulin method, and polybrene method. Combined with the results of antibody identification, the appropriate donor RBC infusion was comprehensively analyzed and selected.

Results

The ABO blood group in the child was AB, RH was CCDee, and the ABO blood group had changed to the donor blood group. The direct antiglobulin test was strongly positive, and the red blood cells were sensitized by antibodies. Irregular antibodies were detected in plasma, and sensitizing antibodies released from RBCs and irregular antibodies detected in plasma were anti-Ce mimicking antibodies. Type AB RBCs with negative Ce antigen avoiding anti-Ce mimicking antibodies were selected. Three days after transfusion, the hemoglobin increased to 79 g/L, and the blood transfusion was effective.

Conclusion

Any type of AHSCT may result in AIHA, that is, there may be some autoantibodies (mimicking antibodies) in plasma which can break the ring of autologous RBCs. If the mimicking antibodies can be identified in a patient's plasma, and a donor without corresponding antigen on RBCs can be screened, the hemolytic transfusion reaction can be avoided to ensure safe and effective blood transfusion.

Key words: Allogeneic hematopoietic stem cell transplantation, Autoimmune hemolytic anemia, Autoantibody, Alloantibody, Mimicking antibody, Safe blood transfusion

表1 本例重度贫血患儿血清与筛查细胞反应格局表

序号	Rh					Kidd		MNS				Duffy		Lewis		P	患儿血清凝集强度
序号	D	C	E	c	e	Jka	Jkb	M	N	S	s	Fya	Fyb	Lea	Leb	P1	Brine多次离心	Gel	Poly
1	+	0	+	+	0	+	0	+	+	0	+	+	0	0	0	0	0	3+	2+
2	+	+	0	0	+	+	+	+	+	+	+	+	+	0	+	0	0	3+	4+
3	+	+	+	+	+	+	+	+	+	0	+	+	0	+	0	+	0	3+	4+

表1 本例重度贫血患儿血清与筛查细胞反应格局表

序号	Rh					Kidd		MNS				Duffy		Lewis		P	患儿血清凝集强度
序号	D	C	E	c	e	Jka	Jkb	M	N	S	s	Fya	Fyb	Lea	Leb	P1	Brine多次离心	Gel	Poly
1	+	0	+	+	0	+	0	+	+	0	+	+	0	0	0	0	0	3+	2+
2	+	+	0	0	+	+	+	+	+	+	+	+	+	0	+	0	0	3+	4+
3	+	+	+	+	+	+	+	+	+	0	+	+	0	+	0	+	0	3+	4+

表2 本例重度贫血患儿血清、酸放散液与谱细胞反应格局

序号	Rh					Kell		Duffy		Kidd		Lewis		P	MNS				血清凝集强度		酸放散液凝集强度
序号	C	D	E	c	e	K	k	Fya	Fyb	JKa	JKb	Lea	Leb	P₁	M	N	S	s	Gel	Poly	Poly（稀释16倍）
1	+	+	0	0	+	0	+	+	0	+	0	0	+	+	+	+	+	0	3+	4+	3+
2	+	+	0	0	+	+	+	0	+	+	+	0	+	+	0	+	0	+	3+	4+	3+
3	0	+	+	+	0	0	+	+	0	+	0	+	0	+	0	+	0	+	3+	2+^w	±
4	0	+	0	+	+	0	+	0	0	+	0	0	0	+	0	+	0	+	3+	2+^s	1+
5	+	0	0	0	+	0	+	+	+	+	+	0	+	+	+	0	+	+	3+	4+	3+
6	0	0	+	+	0	0	+	0	+	+	0	0	+	+	+	+	0	+	3+^s	2+^w	±
7	0	0	0	+	+	+	0	0	+	+	+	0	+	0	+	0	+	0	3+^s	2+^s	1+
8	0	0	0	+	+	0	+	0	+	0	+	+	0	+	+	+	0	+	3+	2+^s	1+
9	0	0	0	+	+	+	+	+	0	+	0	+	0	+	0	+	0	+	3+^s	2+^s	1+
10	0	0	0	+	+	0	+	+	0	+	0	+	0	+	+	0	+	+	3+	2+^s	1+
11	+	+	+	0	+	+	+	+	+	0	+	0	+	0	+	+	+	+	3+^s	4+	3+
12	w	+	+	+	0	0	+	+	0	+	+	0	+	+	+	+	+	+	3+^s	2+	±
13	0	0	+	+	+	0	+	0	+	+	+	0	+	+	0	+	0	+	3+	2+^s	1+
14	+	+	+	+	+	0	+	+	0	0	+	+	0	+	+	+	0	+	3+^s	4+	3+
15	+	0	0	+	+	0	+	0	+	+	0	+	0	+	+	0	+	+	3+^s	4+	3+
16	+	0	0	+	+	0	+	+	+	+	0	0	+	0	+	0	+	+	3+^s	4+	3+

表2 本例重度贫血患儿血清、酸放散液与谱细胞反应格局

序号	Rh					Kell		Duffy		Kidd		Lewis		P	MNS				血清凝集强度		酸放散液凝集强度
序号	C	D	E	c	e	K	k	Fya	Fyb	JKa	JKb	Lea	Leb	P₁	M	N	S	s	Gel	Poly	Poly（稀释16倍）
1	+	+	0	0	+	0	+	+	0	+	0	0	+	+	+	+	+	0	3+	4+	3+
2	+	+	0	0	+	+	+	0	+	+	+	0	+	+	0	+	0	+	3+	4+	3+
3	0	+	+	+	0	0	+	+	0	+	0	+	0	+	0	+	0	+	3+	2+^w	±
4	0	+	0	+	+	0	+	0	0	+	0	0	0	+	0	+	0	+	3+	2+^s	1+
5	+	0	0	0	+	0	+	+	+	+	+	0	+	+	+	0	+	+	3+	4+	3+
6	0	0	+	+	0	0	+	0	+	+	0	0	+	+	+	+	0	+	3+^s	2+^w	±
7	0	0	0	+	+	+	0	0	+	+	+	0	+	0	+	0	+	0	3+^s	2+^s	1+
8	0	0	0	+	+	0	+	0	+	0	+	+	0	+	+	+	0	+	3+	2+^s	1+
9	0	0	0	+	+	+	+	+	0	+	0	+	0	+	0	+	0	+	3+^s	2+^s	1+
10	0	0	0	+	+	0	+	+	0	+	0	+	0	+	+	0	+	+	3+	2+^s	1+
11	+	+	+	0	+	+	+	+	+	0	+	0	+	0	+	+	+	+	3+^s	4+	3+
12	w	+	+	+	0	0	+	+	0	+	+	0	+	+	+	+	+	+	3+^s	2+	±
13	0	0	+	+	+	0	+	0	+	+	+	0	+	+	0	+	0	+	3+	2+^s	1+
14	+	+	+	+	+	0	+	+	0	0	+	+	0	+	+	+	0	+	3+^s	4+	3+
15	+	0	0	+	+	0	+	0	+	+	0	+	0	+	+	0	+	+	3+^s	4+	3+
16	+	0	0	+	+	0	+	+	+	+	0	0	+	0	+	0	+	+	3+^s	4+	3+

表3 血液供者交叉配血试验记录

供者	供者抗原							主侧试验方法
供者	-A	-B	-D	-C	-c	-E	-e	Brine	Gel	Poly
1	+	+	+	+	+	+	+	-	3+^s	4+
2	+	+	+	+	-	-	+	-	3+	3+^s
3	+	+	+	-	+	+	-	-	3+^s	2+^w

表3 血液供者交叉配血试验记录

供者	供者抗原							主侧试验方法
供者	-A	-B	-D	-C	-c	-E	-e	Brine	Gel	Poly
1	+	+	+	+	+	+	+	-	3+^s	4+
2	+	+	+	+	-	-	+	-	3+	3+^s
3	+	+	+	-	+	+	-	-	3+^s	2+^w

1	Szanto CL, Langenhorst J, de Koning C, et al. Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children[J]. Biol Blood Marrow Transplant, 2020, 26(1):114-122. DOI: 10.1016/j.bbmt.2019.07.022.
2	丁苏鄂. 常用血清学检查技术//刘达庄, 朱自严, 包于勤. 免疫血液学[M]. 上海: 上海科学技术出版社, 2002:194-219.
3	向东, 刘曦, 王健莲, 等. 红细胞温自身抗体的血清学特点分析及配血对策[J]. 中国输血杂志, 2008, 21(12):924-926.
4	Holbro A, Passweg JR. Management of hemolytic anemia following allogeneic stem cell transplantation[J]. Hematology Am Soc Hematol Educ Program, 2015, 2015:378-384. DOI: 10.1182/asheducation-2015.1.378.
5	Barcellini W, Fattizzo B, Zaninoni A. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives[J]. J Blood Med, 2019, 10:265-278. DOI: 10.2147/JBM.S190327.
6	Park JA, Lee HH, Kwon HS, et al. Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of post-transplant autoimmune hemolytic anemia[J]. Transfus Med Rev, 2016, 30(1):6-14. DOI: 10.1016/j.tmrv.2015.09.001.
7	Buxbaum NP, Pavletic SZ. Autoimmunity following allogeneic hematopoietic stem cell transplantation[J]. Front Immunol, 2020, 11:2017. DOI: 10.3389/fimmu.2020.02017.
8	González-Vicent M, Sanz J, Fuster JL, et al. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH)[J]. Transfus Med Rev, 2018, DOI: 10.1016/j.tmrv.2018.02.005.
9	Koo J, Giller RH, Quinones R, et al. Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects[J]. Pediatr Blood Cancer, 2020, 67(9):e28591. DOI: 10.1002/pbc.28591.
10	陈华桂, 丁爱华. 临床输血病例解析200例[M]. 湖南,长沙; 湖南科学技术出版社, 2020:17-29.
11	桂嵘, 张志昇, 王勇军. 输血相容性检测及疑难病例分析[M].北京:人民卫生出版社, 2018:89.
12	桂嵘, 陈秉宇, 黄远帅等译. AABB技术手册[M].18版. 长沙:中南大学出版社, 2019:291.
13	Dwyre DM, Clapper A, Heintz M, et al. A red blood cell autoantibody with mimicking anti-E specificity[J]. Transfusion, 2004, 44(9):1287-1292. DOI: 10.1111/j.0041-1132.2004.04112.x.
14	Harvey G, David J, Sally VR. Serologic problem solviing:mollison's blood transfusion in clinical mecicine[M]. New York: Blackwell Publishing, 2005:272-273.
15	Jang MJ, Cho D, Park KU, et al. Autoantibodies with mimicking specificity detected by the dilution technique in patients with warm autoantibodies[J]. Ann Lab Med, 2013, 33(5):343-348. DOI: 10.3343/alm.2013.33.5.343.
16	苑召虎, 杨惠宽, 陈小洁, 等. 2Me、DTT、ZAAP及酶等介质的处理对红细胞JMH抗原的影响[J]. 中国实验血液学杂志, 2019, 27(03):920-924.
17	Issitt PD, Combs MR, Bumgarner DJ, et al. Studies of antibodies in the sera of patients who have made red cell autoantibodies[J]. Transfusion, 1996, 36(6):481-486. DOI: 10.1046/j.1537-2995.1996.36696269503.x.
18	杨小刚, 李碧娟, 舒义刚, 等. 全血置换治疗重度自身免疫性溶血性贫血一例[J]. 临床内科杂志, 2008, 25(6):367-367. DOI: 10.3969/j.issn.1001-9057.2008.06.028.

[1]	陈帅, 刘文宾, 吴迪炯, 俞庆宏, 陈均法, 庄海峰, 胡致平, 武利强, 郑智茵, 沈建平, 叶宝东. 改良FAC预处理方案在不同供者类型行异基因造血干细胞移植治疗再生障碍性贫血中的疗效分析[J]. 中华危重症医学杂志(电子版), 2022, 15(04): 296-299.
[2]	谭洁, 詹森林, 邓国防, 张培泽. 抗干扰素γ自身抗体综合征导致哥伦比亚分枝杆菌播散性感染一例[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(03): 210-214.
[3]	孔欣, 宋宝全, 刘吟, 张剑, 仇惠英, 吴德沛. 异基因造血干细胞移植并发难治性呃逆一例[J]. 中华移植杂志(电子版), 2023, 17(04): 253-255.
[4]	陈敏, 潘田中, 孙自敏. 祛铁治疗异基因造血干细胞移植术后三系植入不良一例[J]. 中华移植杂志(电子版), 2022, 16(03): 168-171.
[5]	赵晶, 丁淑怡, 周晓瑜, 章建丽, 许丽炜, 张力晨, 严佳丽, 程琼, 刘念, 金爱云. 异基因造血干细胞移植后并发慢性移植物抗宿主病患者生活质量变化及其影响因素分析[J]. 中华移植杂志(电子版), 2022, 16(03): 153-159.
[6]	刘恒, 吴涛. 伊布替尼治疗慢性移植物抗宿主病的研究进展[J]. 中华移植杂志(电子版), 2021, 15(05): 317-320.
[7]	刘妍, 吴涛, 毛东锋, 鱼玲玲, 白海. 人类白细胞抗原全相合异基因造血干细胞移植治疗多基因突变难治性急性髓系白血病一例[J]. 中华移植杂志(电子版), 2021, 15(04): 229-231.
[8]	张超琅, 郭晓萍, 赵芬英, 徐晓军. 婴幼儿异基因造血干细胞移植后腹泻伴胰腺再生蛋白3α升高二例[J]. 中华移植杂志(电子版), 2021, 15(02): 116-118.
[9]	张勇, 周合冰. B细胞淋巴瘤/白血病-2抑制剂联合阿扎胞苷治疗急性髓系白血病异基因造血干细胞移植后复发两例[J]. 中华移植杂志(电子版), 2021, 15(01): 45-48.
[10]	刘文慧, 吴涛, 张曦. 间充质干细胞联合血小板生成素受体激动剂在异基因造血干细胞移植后血小板恢复中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 242-246.
[11]	李芸芸, 吴涛, 毛东锋, 鱼玲玲, 刘文慧. 轻型β-地中海贫血供者异基因造血干细胞移植治疗重型再生障碍性贫血1例[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 84-86.
[12]	苏春艳, 吴涛, 毛东锋, 刘文慧, 鱼玲玲, 白海. 异基因造血干细胞移植治疗急性混合细胞白血病后继发外周T细胞淋巴瘤1例[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(05): 289-292.
[13]	胡启桢, 张梅. 胰腺或胰岛移植后1型糖尿病复发的预测[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(06): 364-367.
[14]	王亚飞, 吴振彪. 自身抗体在皮肌炎患者管理中的应用[J]. 中华临床医师杂志(电子版), 2022, 16(08): 796-800.
[15]	杨泽俊, 赵茵. 妊娠期易栓症的自身抗体检测[J]. 中华产科急救电子杂志, 2023, 12(02): 76-80.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in a patient: serological detection methods for mimicking antibodies and blood transfusion strategy

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in a patient: serological detection methods for mimicking antibodies and blood transfusion strategy